Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer

Completed · Phase 3 · Has a placebo group

Conditions studied: Pancreatic Cancer

In brief

The objective of this study is to compare the efficacy and safety of masitinib in combination with gemcitabine to placebo in combination with gemcitabine in patients with advanced/metastatic pancreatic cancer.

Key facts

Study ID
NCT00789633
Run by
AB Science
People needed
353
Starts
2008-11-25
Expected to finish
2012-08-31
Last updated by the study team
2018-12-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.